Home GlaxoSmithKline's experimental HIV, AIDS drug to get priority review
 

Keywords :   


GlaxoSmithKline's experimental HIV, AIDS drug to get priority review

2013-02-19 02:02:39| Biotech - Topix.net

U.S. regulators gave priority review status to an experimental GlaxoSmithKline drug for HIV/AIDS, which industry analysts view as a possible multibillion-dollar-a-year seller.

Tags: review drug aids priority

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.09This Week in Agribusiness, September 28, 2024
28.09This Week in Agribusiness, September 28, 2024
28.09Weekly Recap: AkzoNobel, BASF, Axalta, PPG Top This Weeks Stories
28.09Post-Tropical Cyclone Helene Public Advisory Number 20
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 10
28.09Hurricane Isaac Wind Speed Probabilities Number 10
28.09Hurricane Isaac Public Advisory Number 10
More »